CASSS – Sharing Science Solutions is pleased to announce that Jamie Moore, SVP, Global Head of Technical Development for Gilead Sciences, has been elected Vice President of the CASSS Board of Directors. CASSS board members are elected by the Associate Directors of the organization, a group of volunteers who have contributed significantly to the association. CASSS board officers are elected by their fellow board members to two-year terms.
Reflecting on why she chose to seek the Vice President role, Jamie says, “She continues to be inspired by the mission of bringing together leaders in academia, industry, and health authority agencies to tackle challenging problems to continue to increase access for patients for meaningful products.”
Jamie Moore is currently SVP, Global Head of Technical Development. Prior to that, Moore was at CytomX Therapeutics as the Senior Vice President, Head of Protein & Process Science and Manufacturing. Moore also spent 20 years at Genentech, a Member of the Roche Group in various leadership roles. After receiving her Bachelor of Science degree in chemistry at Graceland University, Jamie received her Ph.D. from the University of California, San Francisco.
Moore’s volunteer positions with CASSS are extensive but highlights include serving as Industry Co-Chair of WCBP and committee member for the North America CMC Strategy Forums. She was also a long-time committee member and symposium chair for the International Symposium on Higher Order Structure of Protein Therapeutics (HOS).
Moore will be leading the board with current CASSS President Julia Edwards of Genentech, a Member of the Roche Group.